Document Detail


Imaging inflammation in stroke using magnetic resonance imaging.
MedLine Citation:
PMID:  20979930     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Stroke is the third leading cause of death, after myocardial infarction and cancer, and the leading cause of permanent disability in Western countries. Although anti-inflammatory drugs have shown very promising results in preclinical rodent studies, they appeared to be ineffective against stroke in clinical trials. In this context, non-invasive detection of inflammatory cells after brain ischemia could be helpful (i) to select patients who may benefit from anti-inflammatory treatment, and/or (ii) to target an adequate individualized therapeutic time window. Magnetic resonance imaging (MRI) coupled with injection of iron oxide nanoparticles, a contrast agent taken up by macrophages ex vivo and in vivo, appears to be a promising tool for this purpose. This review focuses on the use of this technique to image inflammation in pre-clinical and clinical studies of stroke. Despite current limitations, MRI of inflammation may become an important tool for the investigation of novel ischemic stroke therapeutics targeting inflammation.
Authors:
F Chauveau; T H Cho; Y Berthezène; N Nighoghossian; M Wiart
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International journal of clinical pharmacology and therapeutics     Volume:  48     ISSN:  0946-1965     ISO Abbreviation:  Int J Clin Pharmacol Ther     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-28     Completed Date:  2011-01-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423309     Medline TA:  Int J Clin Pharmacol Ther     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  718-28     Citation Subset:  IM    
Affiliation:
CNRS, UMR 5220, Inserm, U630, Insa de Lyon, Creatis, Bron, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Brain Ischemia / diagnosis,  pathology
Ferric Compounds / diagnostic use
Humans
Inflammation / diagnosis*,  etiology
Magnetic Resonance Imaging / methods*
Metal Nanoparticles
Patient Selection
Rodentia
Stroke / diagnosis*,  pathology
Chemical
Reg. No./Substance:
0/Ferric Compounds; 1309-37-1/ferric oxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacokinetic and tolerability profile of once-daily zibotentan (ZD4054) in Japanese and Caucasian...
Next Document:  Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GS...